DR REDDYS LABORATORIES LTD — Capital/Financing Update 2021

Apr 1, 2021

Dr. Roddy'G Loborotorios Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India.

CIN : L85195TG1984PLC004507

Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

April 1, 2021

To, The Secretary BSE Limited National Stock Exchange of India Ltd. New York Stock Exchange Inc. NSE IFSC Limited

Dear Sir/ Madam,

Sub: Intimation under Regulation 30 read with Schedule III of SEBI (Listine Obligation and Disclosm·es Requirements) Regulations, 2015.

We would like to inform you that DigiHealth Technologies LLP, the wholly owned entity of our Indian investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), has agreed to acquire 100% ownership interest in Pharmarack Technologies Private Limited in tranches. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular No. CIR/CFO/CMD/4/2015 dated September 9, 2015 are given in Annexure A to this letter.

This is for your information and record.

Yours faithfully, For r. Reddy's Lab · Limited

\· etary

Encl: As above

ANNEXURE-A

Details as per the Securities and Exchange Board of India circular no. CIR/CFD/CMD/4/2015 dated September 9, 2015

Sr. No.	Particulars	Details
a.	Name of the target entity, details inbrief such as size, turnover etc.	(i)Name of the Target Entity:PharmarackTechnologiesPrivateLimited("Pharmarack").
		(ii)Details of the Target Entity:Pharmarack operates a digital platform aimed atintegrating and solving problems across thepharmaceutical supply chain. Its platform offers/proposes to offer products across supply chainincluding order automation, fulfilment services&optimization,digitalpayments,workingcapitaloptimization,analyticsandmarketinsights.
b.	Whether the acquisition would fallwithin related party transaction(s)andwhether the promoter/promoter group/group companies have any interest inthe entity being acquired? If yes,nature of interest and details thereofand whether the same is one at "armslength"	Not a related party transaction.
C.	Industry to which the entity beingacquired belongs	Healthcare industry.
d.	Objects and effects of acquisition(includingbutnotlimitedto,disclosure of reasons for acquisition oftarget entity, if its business is outsidethe main line' of business of the listedentity)	A step by ABCD Technologies LLP (to berenamed as IndoHealth Services LLP) towardsthe initiative with an objective to facilitate,enableandpromoteefficiencyandGoodDistributionPracticesincluding('GDP')digitizing healthcare infrastructure in India, interalia, in support of the National Digital HealthMission of Government of India ('Business').The acquisition is and will be done by its whollyowned entity DigiHealth Technologies LLP.
e.	Brief details of any governmental orregulatory approvals required for theacquisition	Not Applicable
f.	Indicative time period for completionof the acquisition	Theupfrontacquisitionof91.8%ofshareholding in Pharmarack is expected to becompleted by April 30, 2021 by purchase ofshares from multiple existing shareholders mvarious lots.The remaining 8.2% of the shareholding inPharmarack is likely to be acquired in multipletranches over the next 5 (five) years.

g.	Nature of consideration - whethercash consideration or share swap anddetails of the same	CashconsiderationpayablebyDigiHealthTechnologies LLP.
h.	Cost of acquisition or the price atwhich the shares are acquired	Cost of acquisition to DigiHealth TechnologiesLLP for upfront acquisition of 91.8% is INR 111crores.Cost of acquisition of remaining shareholding
		shallbelinkedtofutureperformanceofPharmarack.
I.	Percentage of shareholding /control acquired and I or numberof shares acquired	Please refer to the response provided in point (f)above.
j.	Brief background about the entityacquired in terms of products/line ofofbusinessacquired,dateincorporation, history of last 3 yearsturnover,countrymwhichtheacquired entity has presence and anyother significant information (in brief)	(i) About the entity:Pharmarack operates a digital platform aimed atintegrating and solving problems across thepharmaceutical supply chain. Its platform offers/proposes to offer products across supply chainincluding order automation, fulfilment services& optimization, digital payments,workingcapitaloptimization,analyticsandmarketinsights.(ii)Date of Incorporation:September 21,2015(iii) Turnover history of last 3 years:2019-2020: INR 4,04,52,773/-2018-2019: INR 2,14,87,907/-2017-2018: INR 64,90,444/-
		(iv)Country: India